- €592.25m
- €808.02m
- €128.92m
- 90
- 10
- 96
- 76
2019 December 31st | 2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | |
---|---|---|---|---|---|
Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
Source: | ARS | ARS | ARS | ARS | ARS |
Standards: | IFRS | IFRS | IFRS | IFRS | IFRS |
Status: | Final | Final | Final | Final | Final |
Revenue | |||||
Total Revenue | 33.7 | 52.1 | 76.4 | 117 | 129 |
Cost of Revenue | |||||
Gross Profit | 20.5 | 29.7 | 45.4 | 72.9 | 86.7 |
Selling / General / Administrative Expenses | |||||
Depreciation and Amortization | |||||
Unusual Expense / Income | |||||
Other Operating Expenses | |||||
Total Operating Expenses | 28.5 | 47.1 | 71.3 | 100 | 109 |
Operating Profit | 5.22 | 5.03 | 5.1 | 16.2 | 19.5 |
Total Net Non Operating Interest Income / Expense | |||||
Other Net Non Operating Costs | |||||
Net Income Before Taxes | 4.99 | 3.63 | 0.786 | 11.4 | 11.7 |
Provision for Income Taxes | |||||
Net Income After Taxes | 5.25 | 2.47 | -0.41 | 7.84 | 8.35 |
Minority Interest | |||||
Net Income Before Extraordinary Items | |||||
Extraordinary Items | |||||
Net Income | 5.01 | 1.59 | -0.981 | 7.85 | 8.29 |
Adjustments to Net Income | |||||
Income Available to Common Shareholders Excluding Extraordinary Items | |||||
Income Available to Common Shareholders Including Extraordinary Items | |||||
Diluted Net Income | 5.01 | 1.59 | -0.981 | 7.85 | 8.29 |
Diluted Weighted Average Shares | |||||
Basic EPS Including Extraordinary Items | |||||
Diluted EPS Including Extraordinary Items | |||||
Diluted EPS Excluding Extraordinary Items | |||||
Normalised Income Before Taxes | |||||
Normalised Income After Taxes | |||||
Normalised Income Available to Common Shareholders | |||||
Diluted Normalised EPS | 0.195 | 0.064 | -0.038 | 0.29 | 0.383 |
Dividends per Share |